NNVC Video Analysisa couple of great golden crossovers are a great sign after this accumulation zone. we could see big things in 2022 with this one
enjoy the video!
Rigo
−0.80USD
−8.59 MUSD
11.24 M
About NanoViricides, Inc.
Sector
CEO
Anil R. Diwan
Headquarters
Shelton
Website
Employees (FY)
7
Founded
2005
ISIN
US6300873022
FIGI
BBG000C0WN63
NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.
$NNVC is gonna fall todayPupm&Dump trading strategy idea.
$NNVC is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $5,17;
stop-loss — $5,44;
take-profit — $4,62/MOC
Do not view
$NNVC is gonna fall todayPupm&Dump trading strategy idea.
$NNVC is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $5,18;
stop-loss — $5,41;
take-profit — $4,72/MOC
Do not view
NNVCNanoViricides, Inc. Pan-coronavirus Clinical Drug Candidates for the Treatment of COVID-19 Are Highly Effective in Pre-clinical Cell Culture Studies Performed in Preparation of FDA Pre-IND Application
NNVC -- You Knew That Was Going to Spike AgainThat shaded box, starting from January.19th, was most likely somebody accumulating..
But it looks like the usual suspects, that being:
Sabby Management
Altrium Capital
Empery Asset Management
CVI Investments
all somehow managed to miss out on this one at the exact same time, because according
Strong pan-coronavirus effectiveness of clinical drug candidatesPan-coronavirus Clinical Drug Candidates for the Treatment of COVID-19 Are Highly Effective in Pre-clinical Cell Culture Studies Performed in Preparation of FDA Pre-IND Application
$NNVC reported yesterday on the strong pan-coronavirus effectiveness of its two COVID-19 clinical drug candidates fo
NNVC Full Detailed Video Analysishi guys in this video i used rs,i macd, elliot wave and the fibonacci retracement and extension tools to give you my perspective on where i believe this asset is going.
enjoy the video and leave a like if you would like for me to revisit this asset in the future.
thanks for your valuable time
rig
NNVC good dip! Hi again, this looks like a nice setup! Going long NNVC at 7.58. My target is 7.95, but it can probably crack 8.00 to 8.22 or so, assuming it heads in that direction. As always, apply your own plan. Pointing out good setups is the best we can do for each other!
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NNVC is 1.13 USD — it has decreased by 3.83% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange NanoViricides, Inc. stocks are traded under the ticker NNVC.
NanoViricides, Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
NNVC stock is 5.31% volatile and has beta coefficient of 0.33. Check out the list of the most volatile stocks — is NanoViricides, Inc. there?
One year price forecast for NanoViricides, Inc. has a max estimate of 6.50 USD and a min estimate of 6.50 USD.
NNVC earnings for the last quarter are −0.17 USD per share, whereas the estimation was −0.17 USD resulting in a 0% surprise. The estimated earnings for the next quarter are −0.19 USD per share. See more details about NanoViricides, Inc. earnings.
Yes, you can track NanoViricides, Inc. financials in yearly and quarterly reports right on TradingView.
NNVC stock has fallen by 12.74% compared to the previous week, the month change is a 1.74% fall, over the last year NanoViricides, Inc. has showed a 14.39% decrease.
NNVC net income for the last quarter is −2.11 M USD, while the quarter before that showed −1.97 M USD of net income which accounts for −7.43% change. Track more NanoViricides, Inc. financial stats to get the full picture.
Today NanoViricides, Inc. has the market capitalization of 13.84 M, it has increased by 9.45% over the last week.
No, NNVC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NNVC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NanoViricides, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 7.00 employees. See our rating of the largest employees — is NanoViricides, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NanoViricides, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NanoViricides, Inc. stock shows the sell signal. See more of NanoViricides, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NanoViricides, Inc. future price: according to them, NNVC price has a max estimate of 6.50 USD and a min estimate of 6.50 USD. Read a more detailed NanoViricides, Inc. forecast: see what analysts think of NanoViricides, Inc. and suggest that you do with its stocks.